MedTrace Logo

DKK3 for Prognosis and Monitoring of GFR Decline in Heart Failure

NCT04111094 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 290

Last updated 2024-05-09

No results posted yet for this study

Summary

The individual course of chronic kidney disease (CKD) may vary, and improved methods for identifying which patients will experience estimated glomerular filtration rate (eGFR) decline are needed. Recently, urinary dickkopf-3 (DKK3) has been proposed to predict eGFR decline in patients with CKD, independent of presence of albuminuria. The investigators sought to examine the association between changes in DKK3 levels and eGFR decline in patients with heart failure (HF).

Conditions

Interventions

DIAGNOSTIC_TEST

No intervention

No intervention

Sponsors & Collaborators

  • University of Giessen

    lead OTHER

Principal Investigators

  • Werner Seeger, MD · University Hospital Giessen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-14
Primary Completion
2023-01-21
Completion
2024-05-06

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04111094 on ClinicalTrials.gov